INT4985
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Partial sciatic nerve ligation was associated with mechanical allodynia, thermal hyperalgesia, and an increase in NK-1 mRNA on the ipsilateral, but not contralateral, side. | |||||||||||||||
| |||||||||||||||
|
Capsaicin- and bradykinin-stimulated extravasation was attenuated by an NK1-receptor antagonist and is thus mediated by release of tachykinins and activation of the NK1 receptor. | |||||||||||||||
| |||||||||||||||
|
In contrast, CP-induced cystitis failed to upregulate the preprotachykinin-A and preproenkephalin genes which encode substance P and enkephalins, respectively in the hypothalamic and limbic nuclei at any of the time points examined. | |||||||||||||||
| |||||||||||||||
|
Disruption of the substance P receptor (neurokinin-1) gene does not prevent upregulation of preprotachykinin-A mRNA in the spinal cord of mice following peripheral inflammation. | |||||||||||||||
| |||||||||||||||
|
These findings suggest that early stimulation of Tac1 is mediated by both genomic and non-genomic E2 pathways. | |||||||||||||||
| |||||||||||||||
|
Therefore, it was interesting to observe that treatment with E2 for 3 h caused a parallel increase in both Tac1 and Tacr1 mRNAs. | |||||||||||||||
| |||||||||||||||
|
Consistent with these findings, 3 h treatment with E2 caused an increase in Tac1 mRNA levels. | |||||||||||||||
| |||||||||||||||
|
Besides SP, peptide hormones such as hemokinin can also bind and activate NK1 at sites of chronic inflammation [44]. | |||||||||||||||
| |||||||||||||||
|
CONCLUSION AND IMPLICATIONS: The analgesic potential of morphine was increased in tac1 knockout mice. | |||||||||||||||
| |||||||||||||||
|
NE neuronal burst activity was increased in NK1 null mutant and wildtype mice given RP67580, but not with RP68651. | |||||||||||||||
| |||||||||||||||
|
Our results support the idea that substance P is an important mediator of thermal hypersensitivity in the setting of nerve injury and suggest that increased NK-1 receptor transcription precedes increased NK-1 receptor density, ultimately leading to behavioral hypersensitivity to peripheral thermal stimulation. | |||||||||||||||
| |||||||||||||||
|
Our results support the idea that substance P is an important mediator of thermal hypersensitivity in the setting of nerve injury and suggest that increased NK-1 receptor transcription precedes increased NK-1 receptor density, ultimately leading to behavioral hypersensitivity to peripheral thermal stimulation. | |||||||||||||||
| |||||||||||||||
|
In conclusion, the 5-hydroxytryptamine-induced tracheal contraction includes a cholinergic mechanism that requires the presence of the tachykinin NK(1) receptor. | |||||||||||||||
| |||||||||||||||
|
PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. | |||||||||||||||
| |||||||||||||||
|
Gastric lesions are caused by an initial detrimental effect of EtOH, which is damaging only if associated with TRPV1 activation, SP release from sensory nerves, stimulation of neurokinin 1 receptors on epithelial cells, and ROS generation. | |||||||||||||||
| |||||||||||||||
|
These findings indicate that concurrent activation of spinal NMDA and substance P receptors induces an enhancement of spinal transmission of nociception, and that this enhancement is dependent on the intensity or the quality of the peripheral stimulus. | |||||||||||||||
| |||||||||||||||
|
Like N/OFQ, nocistatin-induced nociception was abolished by i.pl. injection of pertussis toxin, phospholipase C inhibitor, or CP-99994, a neurokinin 1 receptor antagonist, indicating that nocistatin may elicit nociception through a substance P release from nociceptor endings via activation of Gi/o and phospholipase C. | |||||||||||||||
| |||||||||||||||
|
In conclusion, the NK1 receptor plays a functional role in mediating leukocyte accumulation independently of the historically important NK1 mediated oedema formation. | |||||||||||||||
| |||||||||||||||
|
As SP(5-11) did not down-regulate NK-1 binding, activation of NK-1 sites does not appear necessary or sufficient for down-regulation of SP binding. | |||||||||||||||
| |||||||||||||||
|
Intracerebroventricular (i.c.v.) injection of NK1, NK2 or NK3 receptor antagonists (15-500 pmol/site), all produced significant and dose-dependent inhibition of both phases of the formalin and capsaicin tests. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.